1 |
International Programme on Chemical Safety (IPCS). (1983) Styrene. Environmental Health Criteria 26. World Health Organization, Geneva, pp. 20-50.
|
2 |
Ministry of Employment and Labor (MoEL). (2013) 2013 Annual report for the health examination of workers. Ministry of Employment and Labor.
|
3 |
Watabe, T., Ozawa, N. and Yoshkawa, K. (1981) Stereochemistry in the oxidative metabolism of styrene by hepatic microsomes. Biochem. Pharmacol., 30, 1695-1698.
DOI
|
4 |
Ohtsuji, H. and Ikeda, M. (1971) The metabolism of styrene in rat and the stimulatory effect of phenobarbital. Toxicol. Appl. Pharmacol., 18, 321-328.
DOI
|
5 |
Laffon, B., Pasaro, E. and Mendez, J. (2001) Effects of styrene- 7,8-oxide over p53, p21, bcl-2 and bax expression in human lymphocyte cultures. Mutagenesis, 16, 127-132.
DOI
|
6 |
Chakrabarti, S.K. (2000) Altered regulation of dopaminergic activity and impairment in motor function in rats after subchronic exposure to styrene. Pharmacol. Biochem. Behav., 66, 523-532.
DOI
|
7 |
Husain, R., Srivastava, S.P., Mushtaq, M. and Seth, P.K. (1980) Effect of styrene on levels of serotonin, noradrenalin, dopamine and activity of acetyl cholinesterase and monoamine oxidase in rat brain. Toxicol. Lett., 7, 47-50.
DOI
|
8 |
Sumner, S.J. and Fennell, T.R. (1994) Review of metabolic fate of styrene. Crit. Rev. Toxicol., 24, S11-33.
DOI
|
9 |
American Conference of Government Industrial Hygienists (ACGIH). (2000) Threshold limit values (TLVs) for chemical substances and physical agents and biological exposure indices (BEIs). ACGIH, Cincinnati, OH.
|
10 |
Wenker, M.A., Kezic, S., Monster, A.C. and de Wolff, F.A. (2001) Metabolic capacity and interindividual variation in toxicokinetics of styrene in volunteers. Hum. Exp. Toxicol., 20, 221-228.
DOI
|
11 |
De Palma, G., Manini, P., Mozzoni, P., Andreoli, R., Bergamaschi, E., Cavazzini, S., Franchini, I. and Mutti, A. (2001) Pholimorphism of xenobiotic-metabolizing enzymes and excretion of styrene-specific mercapturic acids. Chem. Res. Toxicol., 14, 1393-1400.
DOI
|
12 |
Haufroid, V., Buchet, J.P., Gardinal, S., Ghittori, S., Imbriani, M., Hirvonen, A. and Lison, D. (2001) Importance of genetic polymorphism in interpreting drug-metabolizing enzymes for the interpretation of biomarkers of exposure of styrene. Biomarkers, 6, 236-249.
DOI
|
13 |
Haufroid, V., Jakubowski, M., Janasik, B., Ligocka, D., Buchet, J.P., Bergamaschi, E., Manini, P., Mutti, A., Ghittori, S., Arand, M., Hangen, N., Oesch, F., Hirvonen, A. and Lison, D. (2002) Interest of genotyping and phenotyping of drugmetabolizing enzymes for the interpretation of biological monitoring of exposure to styrene. Pharmacogenetics, 12, 691-702.
DOI
|
14 |
De Palma, G., Mozzoni, P., Scotti, E., Manini, P., Andreoli, R., Naccarati, A., Mercati, F., Migliore, L. and Mutti, A. (2003) [Genetic polymorphism of biotransforming enzymes and genotoxic effects of styrene]. G. Ital. Med. Lav. Ergon., 25 Suppl 3, 63-64.
|
15 |
Ma, M., Umemura, T., Mori, Y., Gong. Y., Saijo, Y., Sato, F., Kawai, T. and Kishi, R. (2005) Influence of genetic polymorphisms of styrene-metabolizing enzymes and smoking habits on levels of urinary metabolites after occupational exposure to styrene. Toxicol. Lett., 160, 84-91.
DOI
|
16 |
Conccini, T., Di Nucci, A., Tonini, M., Maestri, L., Costa, L.G., Liuzzi, M. and Manzo, L. (1996) Effects of ethanol administration on cerebral non-protein sulfhydryl content in rats exposed to styrene vapour. Toxicology, 106, 115-122.
DOI
|
17 |
NIOSH. (1996) NIOSH manual of analytical methods (4th edition). Method 1501, U.S. Department of Health and Human Services, Cincinnati.
|
18 |
Kim, K.W., Won, Y.L. and Ko, K.S. (2015) Ethnic differences in the metabolism of toluene: coparisons between Korean and foreign workers exposed to toluene. Toxicol. Res., 31, 25-32.
DOI
|
19 |
de Carvalho, D., Lanchote, V.L., Bonato, P.S., Queiroz, R.H., Santos, A.C. and Dreossi, S.A. (1991) A new derivatization procedure for the analysis of hippuric acid and methyl hippuric acid by gaschromatography. Int. Arch. Occup. Environ. Health, 63, 33-37.
DOI
|
20 |
Shaikh, R.S., Amir, M., Masood, A.I., Sohail, A., Athar, H.U., Siraj, S., Ali, M. and Anjam, M.S. (2010) Frequency distribution of GSTM1 and GSTT1 null allele in Parkistani population and risk of disease incidence. Environ. Toxicol. Pharmacol., 30, 76-79.
DOI
|
21 |
Cai, L., Zheng, Z.L. and Zhang, Z.F. (2005) Cytochrome p4502E1 polymorphisms and the risk of gastric cardiac cancer. World J. Gastroenterol., 11, 1867-1871.
DOI
|
22 |
Prieto-Castello, M.J., Cardona, A., Marhuenda, D., Roei, J.M. and Corno, A. (2010) Use of the CYP2E1 genotype and phenotype for the biological monitoring of occupational exposure to styrene. Toxicol. Lett., 192, 34-39.
DOI
|
23 |
Kim, M.R. and Kim, C.W. (2007) Human blood plasma preparation for tow-dimensional gel electrophoresis. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 849, 203-210.
DOI
|
24 |
Bern, M., Sand, K.M., Nilson, J., Sandlie, I. and Andersen, J.T. (2015) The role of albumin receptors in regulation of albumin homeostasis: Implications for drug delivery. J. Controlled Release, 211, 144-162.
DOI
|
25 |
Carbonari, D., Mansi, A., Proietto, A.R., Paci, E., Bonanni, R.C., Gherardi, M., Gatto, M.P., Sisto, R. and Tranfo, G. (2015) Influence of genetic polymorphisms of styrene-metabolizing enzymes on the levels of urinary biomarkers of styrene exposure. Toxicol. Lett., 233, 156-162.
DOI
|